Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center Study to Evaluate the Safety and Effectiveness of the OR3O™ Dual Mobility System in Primary and Revision Total Hip Arthroplasty (THA) Procedures

NCT04325022 is registered in ClinicalTrials.gov with Smith & Nephew, Inc. as lead sponsor.

NCT NCT04325022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center Study to Evaluate the Safety and Effectiveness of the OR3O™ Dual Mobility System in Primary and Revision Total Hip Arthroplasty (THA) Procedures
Lead sponsor
Smith & Nephew, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
July 27, 2020
Completion date
January 31, 2035
Enrollment
177 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

advanced degeneration of the hip joint, revision of the hip joint